Core Viewpoint - The Law Offices of Frank R. Cruz is investigating AVITA Medical, Inc. for potential violations of federal securities laws following significant financial issues related to unpaid claims for its Recell procedures [1][2]. Financial Performance - On August 7, 2025, AVITA Medical reported its second quarter 2025 financial results, indicating a six-month backlog in unpaid provider claims for Recell procedures, which negatively impacted first-half demand [2]. - The backlog was attributed to contractors from the Centers for Medicare & Medicaid Services failing to assign adequate pricing and timely adjudication of claims, leading to uncertainty among providers and reduced utilization of Recell [2]. Stock Market Reaction - Following the announcement of the financial issues, AVITA's stock price dropped by $1.13, or 21%, closing at $4.25 per share on August 8, 2025, resulting in losses for investors [2].
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz